Patent applications published 28 April 2010
Selected patent applications from the weekly European Patents Bulletin
- Treatments of B-cell proliferative disorders
Combinatorx 2178369*
- Combinations for the treatment of B-cell proliferative disorders
Combinatorx 2178370*
- Heterocyclic receptors of cannabinoid receptors
Board of Regents, The University of Texas System 2178371*
- Natural bioactive compounds
Aquapharm Bio-Discovery 2178372*
- Heterocycles as potassium channel modulators
Icagen 2178373*
- Methods of controlling algae with thaxtomin and thaxtomin compsns
Novozymes Biologicals 2178374*
- Pyrazol-[1,5-A]-pyrimidine derivative
Merck Sharp & Dohme 2178375*
- Lupane-type triterpenoids modified at 30-position and analogues thereof
Advanced Life Sciences 2178376*
- Method of combating human head lice
Nettforsk 2178377*
- Method of combating sea lice
Nettforsk 2178378*
- Materials and methods for delivering compsns to selected tissues
The Regents of the University of California 2178499*
- Dry-powder medicament
Norton Healthcare 2178500*
- Pharmaceutical preparations comprising electrochemically activated hypochlorite solutions
Azad Pharma 2178501*
- Sustained delivery of drugs from biodegradable polymeric microparticles
Yale University; University of Iowa Research Foundation 2178502*
- Oral pharmaceutical solutions containing telbivudine
Novartis 2178503*
- Preservative-free prostaglandin-based ophthalmic solution
Laboratoires THEA 2178504*
- Compsns and methods for wound healing
University of Massachusetts Medical School 2178505*
- Preparation of compsns with essentially noncrystalline embedded macrolide antibiotics
Abbott 2178506*
- Pharmaceutical compsn comprising solifenacin or a pharmaceutically acceptable salt thereof
Ratiopharm 2178507*
- Stable formulations of thiadiazole derivative
Eli Lilly; Kyowa Hakko Kirin 2178508*
- Nucleic acid-lipopolymer compsns
Egen 2178509*
- Stable solid pharmaceutical compsn comprising candesartan or pharmaceutically acceptable forms thereof
KRKA 2178510*
- Tableted compsns containing atazanavir
Bristol-Myers Squibb 2178511*
- Tableted compsns containing atazanavir
Bristol-Myers Squibb 2178512*
- Tableted compsns containing atazanavir
Bristol-Myers Squibb 2178513*
- Film coating compsns based on tribasic calcium phosphate
Ideal Cures 2178514*
- Stable compsns
Generics [UK] 2178515*
- Pharmaceutical compsn comprising 11-deoxy-prostaglandin compound and method for stabilising the compound
R-Tech Ueno 2178516*
- Copolymer-stabilised emulsions
The Regents of the University of California 2178517*
- Nanoparticles comprising ionisable, poorly water-soluble cellulosic polymers
Bend Research 2178518*
- Nanoparticles comprising a non-ionisable polymer and an anionic cellulosic polymer
Bend Research 2178519*
- Drug formulations having inert sealed cores
Mylan Pharmaceuticals 2178520*
- Stable medicated chewing gum containing cyclodextrin inclusion complex
Fertin Pharma 2178521*
- Compressed chewing gun tablet comprising taste-masking agent
Fertin Pharma 2178522*
- Transdermal therapeutic systems which contain the substance anastrozole
Bratter, Christian 2178523*
- Microneedle arrays formed from polymer films
Transderm 2178524*
- Resveratrol complex and process for the preparation
Uniao Brasileira De Educaçao E Assistência-Mantenedora Da Pucrs 2178525*
- Injectable pharmaceutical compsns containing panthenol
Prototype Bioforum 2178526*
- Method for activating regulatory T-cells
IMTM 2178527*
- Stabilised tolterodine tartrate formulations
Mylan Pharmaceuticals 2178528*
- Novel application of topical anaesthetics for modulation of neurogenic tremor
Zasler, Nathan; Carpenter, Jeffrey 2178529*
- Medical device and use of pharmaceutical compsn
Biomet Deutschland 2178530*
- Methods, compsn, targets for combinatorial cancer treatments
Yu, Ming 2178531*
- Anti-bacterial drug targeting of genome maintenance interfaces
Wisconsin Alumni Research Foundation 2178532*
- Antiviral compsn comprising a sulphated polysaccharide
Marinomed Biotechnologie 2178533*
- Soluble epoxide hydrolase inhibitors, compsns containing such compounds and methods of treatment
Merck Sharp & Dohme 2178534*
- Compsns and methods for modulating endophthalmitus using fluoroquinolones
Bausch & Lomb 2178535*
- Methods of affecting gastrointestinal transit and gastric emptying, and compounds useful therein
Lexicon Pharmaceuticals 2178536*
- Beta carboline as antidiabetic compounds
Merck Sharp & Dohme 2178537*
- Anti-inflammatory dermatological compsn containing corticosteroids and hyaluronate fragments, and uses thereof
Pierre Fabre Dermo-Cosmétique 2178538*
- Compsns comprising phospholipids
Murray Goulburn Co-Operative 2178539*
- Pharmaceutical compsn suitable for adsorption to the cell surface of pathogenic molecules
Hjertén, Stellan; Hjertén, Marie-Christine; Wadström, Torkel 2178540*
- Polyacetal-carboxylic acids in the treatment of cancer and autoimmune disorders
Katholieke Universiteit Leuven 2178542*
- Lactobacillus rhamnosus and weight control
Nestec 2178543*
- Fraction of Melissa leaf extract having angiogenesis and MMP inhibitory activities, and compsn comprising the same
Angiolab; Kim, Min-Young 2178545*
- Herbal blood formulations for controlling blood glucose levels in patients with diabetes
ATP Marketing & Promotion 2178546*
- Pharmaceutical polypeptide dry powder aerosol formulation and method of preparation
Aerovance 2178547*
- Survivin peptides as cancer vaccines
Health Research 2178548*
- Antimicrobial peptide, compsns, and methods of use
Revance Therapeutics 2178549*
- Methods and compsns for stimulating the proliferation or differentiation of stem cells with substance P or an analogue thereof
Immuneregen Biosciences 2178550*
- Novel peptides with anti-tumour activity
Sanare Investment 2178551*
- The use of type-B antibiotic-based compounds having antimicrobial activity
Novacta Biosystems 2178552*
- Use of a granulin or a granulin-like compound in the therapy or prophylaxis of chronic pains
Johann Wolfgang Goethe-Universität Frankfurt am Main 2178553*
- Treating or ameliorating a neuroinflammatory or demyelinating disorder with prolactin and interferon-8
Stem Cell Therapeutics 2178554*
- Albumin for treating cancer and a pharmaceutical compsn comprising the combination of an antineoplastic agent and albumin
Medestea Research & Production 2178555*
- Protein C for use in maintaining haemostasis
Oregon Health & Science University; The Scripps Research Institute 2178556*
- Compsn of tumour-associated peptides and related anti-cancer vaccine
Immatics Biotechnologies 2178557*
- Yersinia pestis antigens, vaccine compsns and related methods
Fraunhofer USA 2178558*
- Recombinant Vibrio cholerae exo-toxins
The General Hospital Corp 2178559*
- Chimeric HIV antigens
Maxygen 2178560*
- Antibodies to CD200 and uses thereof in inhibiting immune responses
Alexion Pharmaceuticals 2178561*
- Synergistic combinations of VR-1 antagonists and COX-2 inhibitors
Novartis 2178562*
- Combination anti-cancer therapy comprising and inhibitor of both MTORC1 and MTORC2
OSI Pharmaceuticals 2178563*
- Pharmaceutical formulation for delivery of receptor tyrosine kinase inhibiting (RTKI) compounds to the eye
Alcon 2178564*
- Complexes between an amphiphilic polymer and an osteogenic protein of the BMPS family
Adocia 2178565*
- A conjugate of an antibody against CD4 and antifusogenic peptides
F Hoffmann-La Roche 2178566*
- Stabilised immune-modulatory RNA (SIMRA) compounds
Idera Pharmaceuticals 2178567*